Captrust Financial Advisors Madrigal Pharmaceuticals, Inc. Transaction History

Captrust Financial Advisors

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$120.4 - $237.13 $177,469 - $349,529	1,474 New	1,474 $341,000
Q2 2023 Aug 14, 2023	BUY	$203.88 - $312.0 $646,911 - $989,976	3,173 New	3,173 $732,000
Q2 2022 Aug 16, 2022	BUY	$58.04 - $100.2 $58 - $100	1 Added 0.58%	173 $12,000
Q1 2022 May 16, 2022	BUY	$55.89 - $101.89 $2,515 - $4,585	45 Added 35.43%	172 $17,000
Q4 2021 Feb 14, 2022	BUY	$72.34 - $95.09 $217 - $285	3 Added 2.42%	127 $11,000
Q3 2021 Nov 16, 2021	SELL	$78.35 - $105.02 $861 - $1,155	-11 Reduced 8.15%	124 $10,000
Q2 2021 Aug 16, 2021	BUY	$97.2 - $137.59 $3,304 - $4,678	34 Added 33.66%	135 $13,000
Q1 2021 May 17, 2021	BUY	$108.54 - $125.2 $434 - $500	4 Added 4.12%	101 $12,000
Q4 2020 Feb 16, 2021	SELL	$110.06 - $133.7 $171,033 - $207,769	-1,554 Reduced 94.12%	97 $11,000
Q3 2020 Nov 17, 2020	BUY	$99.78 - $124.21 $9,678 - $12,048	97 Added 6.24%	1,651 $195,000
Q1 2020 May 15, 2020	BUY	$66.76 - $93.49 $103,745 - $145,283	1,554 New	1,554 $94,000
Q4 2019 Feb 14, 2020	SELL	$84.28 - $118.5 $130,971 - $184,149	-1,554 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$91.13 - $142.5 $141,616 - $221,445	1,554 New	1,554 $163,000
Q2 2018 Aug 13, 2018	SELL	$101.55 - $313.9 $4,163 - $12,869	-41 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$93.35 - $149.04 $5,320 - $8,495	-57 Reduced 58.16%	41 $4,000
Q4 2017 Feb 14, 2018	BUY	$39.35 - $97.37 $3,856 - $9,542	98	98 $9,000

338

22.7M

757K

960K

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.77B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.